Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatos Onen

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|December 17, 2024
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing SpondylitisSadettin Uslu, Semih Gülle, Gercek Sen, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 19, 2023
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of TofacitinibNevsun Inanc, Kerem Y Abacar, Mehmet A Ozturk, et al.
Seminars in Arthritis and Rheumatism|April 26, 2024
Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritisSema Kaymaz-Tahra, Ozun Bayindir, Burak Ince, et al.
Arthritis Research & Therapy|February 8, 2012
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in TurkeyZiver Sahin, Muge Bıcakcıgil, Kenan Aksu, et al.
International Journal of Rheumatic Diseases|December 18, 2025
Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS ExperienceHasan Kocaayan, Elif Durak Ediboglu, Tuba Demirci Yıldırım, et al.
Arthritis Care & Research|October 10, 2017
Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever PatientsServet Akar, Pınar Cetin, Umut Kalyoncu, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
Internal and Emergency Medicine|April 7, 2026
Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide studyTuba Demirci Yildirim, Esra Erpek, Bahar Özdemir Ulusoy, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Annals of the Rheumatic Diseases|August 22, 2019
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 17, 2024
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing SpondylitisSadettin Uslu, Semih Gülle, Gercek Sen, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 19, 2023
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of TofacitinibNevsun Inanc, Kerem Y Abacar, Mehmet A Ozturk, et al.
Seminars in Arthritis and Rheumatism|April 26, 2024
Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritisSema Kaymaz-Tahra, Ozun Bayindir, Burak Ince, et al.
Arthritis Research & Therapy|February 8, 2012
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in TurkeyZiver Sahin, Muge Bıcakcıgil, Kenan Aksu, et al.
International Journal of Rheumatic Diseases|December 18, 2025
Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS ExperienceHasan Kocaayan, Elif Durak Ediboglu, Tuba Demirci Yıldırım, et al.
Arthritis Care & Research|October 10, 2017
Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever PatientsServet Akar, Pınar Cetin, Umut Kalyoncu, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
Internal and Emergency Medicine|April 7, 2026
Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide studyTuba Demirci Yildirim, Esra Erpek, Bahar Özdemir Ulusoy, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Annals of the Rheumatic Diseases|August 22, 2019
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationLykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling, et al.
Pageof 9